Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Pharmacology|April 2, 2005
Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or proteinA G Pinto, J Horlander, N Chalasani, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999
Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formationD R Jones, J C Gorski, M A Hamman, et al.
European Journal of Clinical Pharmacology|January 1, 1992
The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritisT S Tracy, K Krohn, D R Jones, et al.
Clinical Pharmacology and Therapeutics|October 24, 2001
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activityZ Wang, J C Gorski, M A Hamman, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
In vivo effects of interleukin-10 on human cytochrome P450 activityJ C Gorski, S D Hall, P Becker, et al.
Therapeutic Drug Monitoring|December 1, 1992
Variability in the disposition of ibuprofen enantiomers in osteoarthritis patientsA C Rudy, J D Bradley, S I Ryan, et al.
Clinical Pharmacology and Therapeutics|September 5, 1998
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycinJ C Gorski, D R Jones, B D Haehner-Daniels, et al.
Neuroimage|February 16, 2011
The role of GABAergic modulation in motor function related neuronal network activityS D Hall, I M Stanford, N Yamawaki, et al.
Pageof 11